Patents Assigned to Prosetta Antiviral Inc.
  • Patent number: 10532980
    Abstract: This invention provides, among other things, compounds useful for treating viral infections, pharmaceutical formulations containing such compounds, as well as methods of inhibiting the replication of a virus or treating a disease.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: January 14, 2020
    Assignee: Prosetta Antiviral, Inc.
    Inventors: Suganya Selvarajah, Kumar Paulvannan
  • Patent number: 10195189
    Abstract: This invention provides, among other things, tetrahydroisoquinolines useful for treating viral infections, pharmaceutical formulations containing such compounds, as well as methods of inhibiting the replication of a virus, such as HIV, or treating a disease, such as AIDS.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: February 5, 2019
    Assignee: Prosetta Antiviral, Inc.
    Inventors: Andy Atuegbu, Dennis Solas, Clarence R. Hurt, Anatoliy Kitaygorodskyy
  • Patent number: 10036755
    Abstract: The present invention provides compositions and methods of use in investigations of the formation of mulitprotein assemblies implicated in disease. Also provided are assays for screening candidate compounds of potential utility in preventing and/or treating such diseases by preventing the assembly of or disrupting the function of multiprotein assemblies.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: July 31, 2018
    Assignee: Prosetta Antiviral, Inc.
    Inventors: Vishwanath R. Lingappa, Debendranath Dey
  • Patent number: 9518022
    Abstract: This invention provides, among other things, tetrahydroisoquinolines useful for treating viral infections, pharmaceutical formulations containing such compounds, as well as methods of inhibiting the replication of a virus, such as HIV, or treating a disease, such as AIDS.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: December 13, 2016
    Assignee: Prosetta Antiviral Inc.
    Inventors: Andy Atuegbu, Dennis Solas, Clarence R. Hurt, Anatoliy Kitaygorodskyy
  • Patent number: 9382221
    Abstract: Novel methods and compounds for treating Alzheimer's Disease are provided. In one aspect, the invention provides methods for treating Alzheimer's Disease by administering certain phenothiazine derivatives. In one embodiment, the methods include administering an effective amount of a 3-oxo-7-dialkyl-amino-phenothiazine derivative, or 3-oxo-7-dialkyl-amino-phenothiazine. In another embodiment, the invention provides methods for treating Alzheimer's Disease by administering an effective amount of a 3,7-diazetidin-1-yl-phenothiazine or a derivative thereof. In another aspect, the invention provides novel azetidinyl phenothiazine compounds.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: July 5, 2016
    Assignee: Prosetta Antiviral Inc.
    Inventors: Vishwanath Lingappa, Clarence R. Hurt
  • Patent number: 8828986
    Abstract: Compounds and methods for preventing and treating viral infections are provided. In some embodiments, novel compounds broad-spectrum antiviral activity are provided. In more specific embodiments, the compounds and methods are effective against viruses such as Venezuelan Equine Encephalitis, West Nile Virus, and Hepatitis C.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: September 9, 2014
    Assignee: Prosetta Antiviral Inc.
    Inventors: Clarence Hurt, Andy Atuegbu, Anatoliy Kitaygorodskyy, Beverly Freeman, Vishwanath Lingappa
  • Patent number: 8809317
    Abstract: Compounds and methods for preventing and treating viral infections are provided. In some embodiments, novel compounds broad-spectrum antiviral activity are provided. In more specific embodiments, the compounds and methods are effective against viruses such as Venezuelan Equine Encephalitis, West Nile Virus, and Hepatitis C.
    Type: Grant
    Filed: March 29, 2012
    Date of Patent: August 19, 2014
    Assignee: Prosetta Antiviral Inc.
    Inventors: Clarence R. Hurt, Vishwanath Lingappa, Beverly Freeman, Andy Atuegbu, Anatoliy Kitaygorodskyy
  • Patent number: 8796448
    Abstract: Novel methods and compounds for treating Alzheimer's Disease are provided. In one aspect, the invention provides methods for treating Alzheimer's Disease by administering certain phenothiazine derivatives. In one embodiment, the methods include administering an effective amount of a 3-oxo-7-dialkyl-amino-phenothiazine derivative, or 3-oxo-7-dialkyl-amino-phenothiazine. In another embodiment, the invention provides methods for treating Alzheimer's Disease by administering an effective amount of a 3,7-diazetidin-1-yl-phenothiazine or a derivative thereof. In another aspect, the invention provides novel azetidinyl phenothiazine compounds.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: August 5, 2014
    Assignee: Prosetta Antiviral Inc.
    Inventors: Vishwanath Lingappa, Clarence R. Hurt
  • Patent number: 8785434
    Abstract: Compounds and methods for preventing and treating viral infections are provided. In some embodiments, novel compounds broad-spectrum antiviral activity are provided. In more specific embodiments, the compounds and methods are effective against viruses such as Venezuelan Equine Encephalitis, West Nile Virus, and respiratory viruses including the common cold.
    Type: Grant
    Filed: May 2, 2011
    Date of Patent: July 22, 2014
    Assignee: Prosetta Antiviral Inc.
    Inventors: Clarence R. Hurt, Vishwanath Lingappa, Beverly Freeman, Andy Atuegbu, Anatoliy Kitaygorodskyy
  • Patent number: 8759336
    Abstract: Novel compounds, methods, and compositions for treating various viral infections are described. In some embodiments the novel compounds of the invention are 3-oxo-phenothiazine derivatives; more specific embodiments include 3-oxo-phenothiazine derivatives having substituents at the 1-, 7-, and 9-positions of the phenothiazine parent ring. In other embodiments, the invention provides compositions and methods for treating viral infections, especially HIV.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: June 24, 2014
    Assignee: Prosetta Antiviral Inc.
    Inventors: Clarence R. Hurt, Vishwanath Lingappa, Beverly Freeman, Andy Atuegbu, Anatoliy Kitaygorodorskyy
  • Publication number: 20140106365
    Abstract: The present invention provides compositions and methods of use in investigations of the formation of multiprotein assemblies implicated in disease. Also provided are assays for screening candidate compounds of potential utility in preventing and/or treating such diseases by preventing the assembly of or disrupting the function of multiprotein assemblies.
    Type: Application
    Filed: July 24, 2013
    Publication date: April 17, 2014
    Applicant: Prosetta Antiviral, Inc.
    Inventors: Vishwanath R. LINGAPPA, Debendranath Dey
  • Publication number: 20130053267
    Abstract: The invention provides a cell-free system comprising not more than about 5% wheat germ extract for expressing proteins such as viral proteins and proteins required for viral capsid assembly, and proteins that assemble into multiprotein complexes in a manner analogous to viral capsids, are provided. Further provided are methods for expressing proteins such as viral proteins, proteins required for capsid assembly, and proteins that assemble into multiprotein complexes in a manner analogous to viral capsids using a cell-free system comprising not more than about 5% wheat germ extract. Further provided are methods to assay for compounds that modulate viral protein, viral capsid assembly, and assembly of proteins into multiprotein complexes whose disruption can ameliorate bacterial, parasitic, metabolic, oncologic, immunologic, or CNS disease in a cell-free system comprising not more than about 5% wheat germ extract.
    Type: Application
    Filed: August 3, 2012
    Publication date: February 28, 2013
    Applicant: PROSETTA ANTIVIRAL, INC.
    Inventor: Vishwanath R. LINGAPPA
  • Publication number: 20120301904
    Abstract: The present invention provides compositions and methods of use in investigations of the formation of mulitprotein assemblies implicated in disease. Also provided are assays for screening candidate compounds of potential utility in preventing and/or treating such diseases by preventing the assembly of or disrupting the function of multiprotein assemblies.
    Type: Application
    Filed: April 26, 2012
    Publication date: November 29, 2012
    Applicant: Prosetta Antiviral, Inc
    Inventors: Vishwanath R. Lingappa, Clarence R. Hurt, Debendranath Dey
  • Publication number: 20120302556
    Abstract: Compounds and methods for preventing and treating viral infections are provided. In some embodiments, novel compounds broad-spectrum antiviral activity are provided. In more specific embodiments, the compounds and methods are effective against viruses such as Venezuelan Equine Encephalitis, West Nile Virus, and Hepatitis C.
    Type: Application
    Filed: March 29, 2012
    Publication date: November 29, 2012
    Applicant: PROSETTA ANTIVIRAL INC.
    Inventors: Clarence R. Hurt, Vishwanath Lingappa, Beverly Freeman, Andy Atuegbu, Anatoliy Kitaygorodskyy
  • Publication number: 20120270854
    Abstract: Compounds and methods for preventing and treating viral infections are provided. In some embodiments, novel compounds broad-spectrum antiviral activity are provided. In more specific embodiments, the compounds and methods are effective against viruses such as Venezuelan Equine Encephalitis, West Nile Virus, and Hepatitis C.
    Type: Application
    Filed: April 20, 2012
    Publication date: October 25, 2012
    Applicant: PROSETTA ANTIVIRAL INC.
    Inventors: Clarence Hurt, Vishwanath Lingappa, Beverly Freeman, Anatolly Kitaygorodskyy, Andy Atuegbu
  • Publication number: 20120238543
    Abstract: Novel compounds, methods, and compositions for treating various viral infections are described. In some embodiments the novel compounds of the invention are 3-oxo-phenothiazine derivatives; more specific embodiments include 3-oxo-phenothiazine derivatives having substituents at the 1-, 7-, and 9-positions of the phenothiazine parent ring. In other embodiments, the invention provides compositions and methods for treating viral infections, especially HIV.
    Type: Application
    Filed: March 16, 2012
    Publication date: September 20, 2012
    Applicant: Prosetta Antiviral, Inc.
    Inventors: Clarence Hurt, Beverly Freeman, Vishwanath Lingappa, Andy Atuegbu, Anatoliy Kitaygorodskyy
  • Patent number: 8227459
    Abstract: Compounds and methods for preventing and treating viral infections are provided. In some embodiments, novel compounds broad-spectrum antiviral activity are provided. In more specific embodiments, the compounds and methods are effective against viruses such as Venezuelan Equine Encephalitis, West Nile Virus, and Hepatitis C.
    Type: Grant
    Filed: April 3, 2008
    Date of Patent: July 24, 2012
    Assignee: Prosetta Antiviral Inc.
    Inventors: Jacob Plattner, Colm Kelleher, Vishwanath Lingappa, Beverly Freeman, William Hansen
  • Publication number: 20120157435
    Abstract: Compounds and methods for preventing and treating viral infections are provided. In some embodiments, novel compounds broad-spectrum antiviral activity are provided. In more specific embodiments, the compounds and methods are effective against viruses such as Venezuelan Equine Encephalitis, West Nile Virus, and respiratory viruses including the common cold.
    Type: Application
    Filed: May 2, 2011
    Publication date: June 21, 2012
    Applicant: PROSETTA ANTIVIRAL INC.
    Inventors: Clarence Hurt, Beverly Freeman, Vishwanath Lingappa, Andy Atuegbu, Anatoliy Kitaygorodorskyy